Aurobindo Racks Up Another Biosimilar Nod With Filgrastim In UK

CuraTeQ Subsidiary Receives MHRA Approval For Zefylti Version

 
• By Dave Wallace
  
Aurobindo’s CuraTeQ has another biosimilar approval (Shutterstock)

More from Biosimilars

More from Business